In accordance with the NMPA approval, Gyre intends to pursue an adaptive Phase 2/3 clinical trial design, combining dose exploration with efficacy confirmation, to efficiently evaluate pirfenidone's ...

Offshore Energies UK (OEUK), the trade body for North Sea oil and gas operators, which counts Shell as a member – but whose ...